Analysis of Virechana Karma with Trivritta Avaleha: A Retrospective Study

Authors

  • Satyajit Pandurang Kulkarni Professor and HOD, Department of Panchakarma, Manjushree Research Institute in Ayurvedic Science, Piplaj, Gandhinagar, Gujarat, India
  • Shivananda S. Tonde Associate Professor and HOD, Department of Swasthavritta, Ayurved Seva Sangh’s Ayurved Mahavidyalay, Panchvati, Nashik, Maharashtra, India
  • Yashwant R. Patil Dean and Professor, Department of Swasthavritta, Government Ayurvedic College, Vazirabad, Nanded, Maharashtra, India

Keywords:

Virechana Karma, Trivritta Avaleha, Virechak Dravya dose, Koshtha, Uttam Shuddhi

Abstract

The Virechana (therapeutic purgation) is one of the popular Panchakarma procedures which has been performed to maintain the health and treat various ailments such as constipation, skin diseases, menstrual disorders etc. The ancient classical texts have described the procedure of Virechana Karma in detail, but, it becomes practically difficult to perform the Virechana Karma as the drugs mentioned for Virechana Karma in the classical texts are either not available in the market or the dose mentioned in the texts is not in present terminology. Trivritta (Operculina turpethum) is such a drug which is used in the form of Trivritta Avaleha available in the market. The Trivritta is mentioned as the best drug for Virechana (therapeutic purgation). But analysis of Virechana Karma with Trivritta Avaleha is not studied yet. Therefore, it becomes difficult to decide the dose of Trivitta Avaleha for Virechana Karma. Chaganti and Prasad carried out analysis of Danti Avaleha, which is another drug for Virechana, however such kind of study of Trivritta Avaleha has been not carried out yet. Therefore, the present study was carried out. In this case series, total 13 healthy individuals were observed from the initiation of the course to end with special reference to the dose of Trivirtt Avaleha and outcome of Virechana. It was observed that out of 13 individuals, eight  had Pravara (excellent) Shuddhi, four had Madhyama (medium) Shuddhi and one individual having Avara (minimum) Shuddhi. In the end, it was concluded that 25 g is the minimum effective dose of Trivritt Avaleha for Virechana in Madhyama Koshtha and it is 30 g in case of Krur Koshtha.

Author Biography

  • Satyajit Pandurang Kulkarni, Professor and HOD, Department of Panchakarma, Manjushree Research Institute in Ayurvedic Science, Piplaj, Gandhinagar, Gujarat, India
    Professor in Panchakarma

References

Pandit KS, Chaturvedi GN, et al. Charaka Samhita of Agnivesha Siddhisthana 2/13. Varanasi, India: Chaukhambha Bharati Academy; 2001. 981p.

Pandit KS, Chaturvedi GN, et al. Charaka Samhita of Agnivesha Siddhisthana 2/13. Varanasi, India: Chaukhambha Bharati Academy; 2001. 981p.

Dave A, Shingala T, Kumari J, Mehta C, Shukla V. A comparative clinical study of Nyagrodhadi Ghanavati and Virechana Karma in the management of Madhumeha. Ayu (An Int Q J Res Ayurveda). 2010; 31(3): 300–304p.

Mangal G, Sharma R, Mangal G. Clinical efficacy of Shodhana Karma and Shamana Karma in Mandala Kushtha (Psoriasis). Ayu (An Int Q J Res Ayurveda). 2012; 33(2): 224–229p.

Chaganti S, Prasad BS. Analysis of Virechana karma with Danti avaleha: A retrospective study. J Ayurveda Integr Med. 2015; 6(4): 300–304p.

Chaturvedi A, Rao PN, Kumar MA, Ravishankar B, Rao N, Ravi M. Effect and Mechanism of Virechana Karma (Therapeutic Purgation) Over Fructose-Induced Metabolic Syndrome: An Experimental Study. J Evidence-Based Complement Altern Med. 2016; 21(3): 194–201p.

Kolhe R, Acharya RN. Trivrut and Its Important in the Classical Text of Ayurveda : A Comprehensive Review. 2014; 1(2): 33–53p.

Rais A, Bhatted S. Clinical study to evaluate the effect of Virechanakarma on serum electrolytes. Ayu (An Int Q J Res Ayurveda). 2013; 34(4): 379–382p.

Shastri PK, Chaturvedi GN, et al. Charaka Samhita of Agnivesha Siddhisthana 2/13. Varanasi, India: Chaukhambha Bharati Academy; 2001. 981p.

Sharma M, Parashar B, Kalpana, Devi N. Formulation and Evaluation of Hingwashtak Churna for Digestive Property: A Research. World Journal of Pharmaceutical Research. 2019; 8(7): 2332–2344p.

Vagbhata. Ashtang Hridaya. Tripathi DB, Editor. Varanasi: Chaukhambha; 2019. 1379p.

Chaganti S, Prasad BS. Analysis of Virechana karma with Danti avaleha: A retrospective study. J Ayurveda Integr Med. 2015; 6(4): 300–304p.

Chaturvedi A, Rao PN, Kumar MA, Ravishankar B, Rao N, Ravi M. Effect and Mechanism of Virechana Karma (Therapeutic Purgation) Over Fructose-Induced Metabolic Syndrome: An Experimental Study. J Evidence-Based Complement Altern Med. 2016; 21(3): 194–201p.

Downloads

Published

2021-11-01

Issue

Vol. 10 No. 3 (2021)

Section

Case Study

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.